HARP - Harpoon Therapeutics GAAP EPS of -$0.55 misses by $0.08 revenue of $4.1M misses by $2.94M
2023-03-27 17:13:08 ET
- Harpoon Therapeutics press release ( NASDAQ: HARP ): Q4 GAAP EPS of -$0.55 misses by $0.08 .
- Revenue of $4.1M (-5.3% Y/Y) misses by $2.94M .
- Shares -4.26% AH.
For further details see:
Harpoon Therapeutics GAAP EPS of -$0.55 misses by $0.08, revenue of $4.1M misses by $2.94M